(MNTA) Alert: Johnson Fistel Investigates Proposed Sale of Momenta Pharmaceuticals; Are Shareholders Getting a Fair Price?
- Wednesday, August 19, 2020, 7:01
- Finance
- Add a comment
SAN DIEGO, Aug. 19, 2020 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Momenta Pharmaceuticals, Inc. (“Momenta” or the “Company”) (NASDAQ: MNTA) breached their fiduciary duties in connection with the…
About the Author
adminasapcorp has written 42168 stories on this site.